HABA LABORATORIES,INC. (4925.T) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	12.1B	12.1B	12.1B	12.3B	12.0B
Cost of Revenue	871.9M	4.1B	4.0B	3.9B	3.9B
Gross Profit	1.8B	8.1B	8.1B	8.4B	8.2B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	1.7B	7.4B	7.5B	8.6B	8.8B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	1.7B	7.4B	7.5B	8.6B	8.8B
Cost and Expenses	11.4B	11.4B	11.5B	12.5B	12.6B
Operating Income (EBIT)	727.0M	727.0M	589.0M	(187.0M)	(609.0M)
Non-Operating
Interest Income	—	2.4M	502.0K	26.0K	58.0K
Interest Expense	4.2M	16.8M	17.0M	9.7M	6.1M
Net Interest Income	(4.2M)	(14.4M)	(16.5M)	(9.7M)	(6.0M)
Other Non-Op Income/Expense	(2.4M)	(19.2M)	19.5M	(3.7M)	27.0M
Non-Operating Income (excl Interest)	1.9M	11.1M	36.4M	6.9M	34.0M
EBT (Pre-Tax Income)	58.0M	850.0M	635.7M	(1.8B)	(548.7M)
Income Tax Expense	16.9M	89.7M	59.2M	275.3M	159.2M
Bottom Line
Net Income	760.0M	760.0M	576.0M	(2.1B)	(707.0M)
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	760.0M	760.0M	576.0M	(2.1B)	(707.0M)
Per Share
Basic EPS	¥201	¥201	¥152	(¥560)	(¥187)
Diluted EPS	¥201	¥201	—	—	—
Revenue Per Share	¥3,211	¥3,211	¥3,189	¥3,259	¥3,183
Shares
Basic Shares Outstanding	3.8M	3.8M	3.8M	3.8M	3.8M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	913.2M	747.8M	332.3M	(49.3M)
D&A	—	186.2M	158.8M	519.3M	559.7M
EBIT	727.0M	727.0M	589.0M	(187.0M)	(609.0M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026